Brusatol, an NRF2 inhibitor for future cancer therapeutic
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Cai, Sabrina J.
Text and Data Mining valid from 2019-06-06
Version of Record valid from 2019-06-06
27 May 2019
30 May 2019
6 June 2019
Ethics approval and consent to participate
The authors declare that they have no competing interests.